Clinical Trial Update: A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 cooperative trial evaluating abatacept in relapsing-remitting multiple sclerosis has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED | Results posted: 2016-04-08